Dr Liu is a Research Fellow in Centre for Eye Research Australia and Department of Ophthalmology at University of Melbourne. Dr Liu completed his doctorate in biochemistry/gene engineering at Kaohsiung Medical University (Taiwan, 2006) and postdoctoral training in Pharmacology/Vascular Biology from O’Brien Institute from 2009 to 2011. His current research has focus on understanding the angiogenesis within the eye (termed ocular neovascularisation) and building a platform of research based on angiogenesis for drug discovery as well as ocular gene therapy, with a particular interest in directing future work into clinical research. Currently, Dr Liu is leading a team charged with developing gene therapies to prevent and delay blindness in major eye diseases that result from pathological neovascularisation.
Tissue Engineering and Regenerative Medicine International Society (TERMIS).
Full Member 2013 - 2016
American Society of Gene & Cell Therapy (ASGCT).
Associated Member 2013 - 2015
Australasian Gene Therapy Society.
Full Member 2013
the Association for Research in Vision and Ophthalmology (ARVO).
Full Member 2013
2014 NHMRC Project Grant (CIB). New treatment to block retinal blood vessel growth avoiding eye surgery. 2014 Angior Family Foundation (Chief Investigator). A novel topical medication to prevent loss of vision in a degenerative eye disease in the elderly. 2014 SSF-International Collaboration Project, China. Identification of Anthocyanin types controlling the extent of myopia and the direct mechanism of action. 2013 ORIA Research Grant (Chief Investigator). Gene delivery of a new drug for aberrant development of blood vessels. 2013University of Melbourne Early Career Researcher Fellowship (Chief Investigator). Vasostatin: A potential new drug for the treatment of vision loss.
Education and training
Kaohsiung Medical University 2006
Awards and honors
The CASS Foundation Travel Award,
2013 ZOC/SKLO Travel Award,
Harold Mitchell Travel Award,
Young Investigator Award, International Symposium of Materials on Regenerated Medicine (2012 ISOMRM),